NCT01381471View on ClinicalTrials.gov

Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL

Enrollment

11,060

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone propionate/salmeterol xinafoate combination

fluticasone propionate/salmeterol xinafoate combination

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY